Hematologic Oncology Update cover image

Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma

Hematologic Oncology Update

CHAPTER

Challenges of Generating Order Sets and Management of Conditional Toxicity in a New Therapy

The chapter discusses the difficulties in predicting and managing conditional toxicity when generating order sets for a new therapy. Community oncologists are encouraged to gain access and include the therapy in their pathways.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner